Literature DB >> 18605258

A national approach to teaching complementary and alternative medicine in Canadian medical schools: The CAM in UME project.

Marja J Verhoef1, Rebecca Brundin-Mather.   

Abstract

Complementary and Alternative Medicine (CAM) is increasingly used in North America. Most patients combine conventional and CAM treatments, however, The widespread use of CAM is not without concern. The growing use of CAM is drawing more and more attention from individuals involved in medical education. We present an overview of a national initiative to integrate CAM in undergraduate medical education (UME) programs in Canada. The aim of this initiative, called the CAM in UME Project, is to facilitate high quality and balanced teaching of CAM related issues in UME. The project's activities include the development of (1) CAM-oriented competencies, (2) peer-reviewed summaries of topics relevant to CAM, (3) a searchable repository of teaching and learning resources, and (4) a guide for the development, implementation and sustainability of CAM curriculum. All these are housed on the CAM in UME Web site (http://www.caminume.ca) which is freely accessible to interested individuals. It appears that teaching students about natural health products, an important component of CAM, would be a natural fit for pharmacologists based at medical schools.

Entities:  

Mesh:

Year:  2007        PMID: 18605258

Source DB:  PubMed          Journal:  Proc West Pharmacol Soc        ISSN: 0083-8969


  2 in total

1.  Complementary and alternative medicine education for medical profession: systematic review.

Authors:  Nana K Quartey; Polly H X Ma; Vincent C H Chung; Sian M Griffiths
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-30       Impact factor: 2.629

2.  A survey of Canadian regulated complementary and alternative medicine schools about research, evidence-based health care and interprofessional training, as well as continuing education.

Authors:  Karine Toupin April; Isabelle Gaboury
Journal:  BMC Complement Altern Med       Date:  2013-12-28       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.